Martien Van Wenum

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Effect of an early time restricted eating Mediterranean diet compared to naltrexone/bupropion on liver fibrosis in people with cardiometabolic risk factors in a hospital outpatient clinic: study protocol for a randomised controlled trial (MEDFAST trial).

Effect of an early time restricted eating Mediterranean diet compared to naltrexone/bupropion on liver fibrosis in people with cardiometabolic risk factors in a hospital outpatient clinic: study protocol for a randomised controlled trial (MEDFAST trial).

Journal: BMJ open

Published: June 25, 2026

Assessing the effects of naltrexone-bupropion on hepatic steatosis and fibrosis in patients with T2DM and overweight or obesity: Insights from a placebo-controlled trial.

Assessing the effects of naltrexone-bupropion on hepatic steatosis and fibrosis in patients with T2DM and overweight or obesity: Insights from a placebo-controlled trial.

Journal: Diabetes, obesity & metabolism

Published: July 01, 2025

Oxygen drives hepatocyte differentiation and phenotype stability in liver cell lines.

Oxygen drives hepatocyte differentiation and phenotype stability in liver cell lines.

Journal: Journal of cell communication and signaling

Published: November 30, 2017

HepaRG-Progenitor Cell Derived Hepatocytes Cultured in Bioartificial Livers Are Protected from Healthy- and Acute Liver Failure-Plasma Induced Toxicity.

HepaRG-Progenitor Cell Derived Hepatocytes Cultured in Bioartificial Livers Are Protected from Healthy- and Acute Liver Failure-Plasma Induced Toxicity.

Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

Published: August 29, 2017

Scaling-up of a HepaRG progenitor cell based bioartificial liver: optimization for clinical application and transport.

Scaling-up of a HepaRG progenitor cell based bioartificial liver: optimization for clinical application and transport.

Journal: Biofabrication

Published: July 01, 2017

AMC-Bio-Artificial Liver culturing enhances mitochondrial biogenesis in human liver cell lines: The role of oxygen, medium perfusion and 3D configuration.

AMC-Bio-Artificial Liver culturing enhances mitochondrial biogenesis in human liver cell lines: The role of oxygen, medium perfusion and 3D configuration.

Journal: Mitochondrion

Published: May 12, 2017

Selecting Cells for Bioartificial Liver Devices and the Importance of a 3D Culture Environment: A Functional Comparison between the HepaRG and C3A Cell Lines.

Selecting Cells for Bioartificial Liver Devices and the Importance of a 3D Culture Environment: A Functional Comparison between the HepaRG and C3A Cell Lines.

Journal: International journal of biological sciences

Published: February 01, 2016

Pivotal preclinical trial of the spheroid reservoir bioartificial liver.

Pivotal preclinical trial of the spheroid reservoir bioartificial liver.

Journal: Journal of hepatology

Published: May 16, 2015

Bioartificial livers in vitro and in vivo: tailoring biocomponents to the expanding variety of applications.

Bioartificial livers in vitro and in vivo: tailoring biocomponents to the expanding variety of applications.

Journal: Expert opinion on biological therapy

Published: November 05, 2014

Showing 1-9 of 9

Last Updated: 09/26/2026